HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Blanco, I. Articles by Miravitlles, M. Search for Related Content PubMed PubMed Citation Articles by Blanco, I. Articles by Miravitlles, M.

Estimated numbers and prevalence of PI*S and PI*Z alleles of ₁-antitrypsin deficiency in European countries

¹ Internal Medicine Division, Respiratory Diseases Branch, Hospital Valle del Nalon, Langreo, Principado de Asturias, ³ Bio-statistics Unit, Hospital Universitario Central de Asturias, Oviedo, Principado de Asturias, and ⁴ Servei de Pneumologia, Institut Clinic del Torax, IDIBAPS, Red Respira RTIC 03/11 ISCIII, Hospital Clinic, Barcelona, Catalonia, Spain. ² Laboratory of Molecular Toxicology, Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.

CORRESPONDENCE: I. Blanco, Dept of Internal Medicine, Respiratory Diseases Branch, Hospital Valle del Nalón, 33920 Langreo, Principado de Asturias, Spain. Fax: 34 985652006. E-mail: ignacio.blanco{at}sespa.princast.es/ignablanco{at}yahoo.es

Keywords: ₁-Antitrypsin deficiency, ₁-protease inhibitor, Europe, genetic epidemiology, protease inhibitor phenotypes

Received: May 30, 2005
Accepted August 15, 2005

The current study focuses on developing estimates of the numbers of individuals carrying the two most common deficiency alleles, PI*S and PI*Z, for ₁-antitrypsin deficiency (AT-D) in Europe.

Criteria for selection of epidemiological studies were: 1) AT phenotyping performed by isoelectrofocusing or antigen–antibody crossed electrophoresis; 2) rejection of "screening studies"; 3) statistical precision factor score of 5 for Southwest, Western and Northern Europe, 4 for Central Europe, 3 for Eastern Europe; and 4) samples representative of the general population.

A total of 75,390 individuals were selected from 21 European countries (one each from Austria, Belgium, Latvia, Hungary, Serbia-Montenegro, Sweden and Switzerland; two each from Denmark, Estonia and Lithuania; three each from Portugal and the UK; four each from Finland, the Netherlands, Norway and Spain; five each from Russia and Germany; six from Poland; eight from Italy; and nine from France). The total AT-D populations of a particular phenotype in the countries selected were: 124,594 ZZ; 560,515 SZ; 16,323,226 MZ; 630,401 SS; and 36,716,819 MS. The largest number of ZZ (5,000–15,000) were in Italy, Spain, Germany, France, the UK, Latvia, Sweden and Denmark, followed by Belgium, Portugal, Serbia-Montenegro, Russia, The Netherlands, Norway and Austria (1,000–2,000), with <1,000 in each of the remaining countries.

A remarkable lack in number of reliable epidemiological studies and marked differences among these European countries and regions within a given country was also found.

This article has been cited by other articles:

				D. K. Hogarth and G. Rachelefsky Screening and Familial Testing of Patients for {alpha}1-Antitrypsin Deficiency Chest, April 1, 2008; 133(4): 981 - 988. [Abstract] [Full Text] [PDF]

				J. M. Brehm and J. C. Celedon Chronic Obstructive Pulmonary Disease in Hispanics Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 473 - 478. [Abstract] [Full Text] [PDF]

				G. Tirado-Conde, B. Lara, and M. Miravitlles Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency Therapeutic Advances in Respiratory Disease, February 1, 2008; 2(1): 13 - 21. [Abstract] [PDF]

				K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555. [Abstract] [Full Text] [PDF]

				R. A. Stockley, M. Luisetti, M. Miravitlles, E. Piitulainen, P. Fernandez, and on behalf of the Alpha One International Registry Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development Eur. Respir. J., March 1, 2007; 29(3): 582 - 586. [Abstract] [Full Text] [PDF]

				M. P. Kaczor, M. Sanak, and A. Szczeklik Rapid and Inexpensive Detection of {alpha}1-Antitrypsin Deficiency-Related Alleles S and Z by a Real-Time Polymerase Chain Reaction Suitable for a Large-Scale Population-Based Screening J. Mol. Diagn., February 1, 2007; 9(1): 99 - 104. [Abstract] [Full Text] [PDF]

				F. J. de Serres, I. Blanco, and E. Fernandez-Bustillo Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of {alpha}1-antitrypsin deficiency in Asia Eur. Respir. J., December 1, 2006; 28(6): 1091 - 1099. [Abstract] [Full Text] [PDF]

				D. A. Lomas The Selective Advantage of {alpha}1-Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1072 - 1077. [Abstract] [Full Text] [PDF]